About

Lloyd M. Segal has served on Aktis Oncology's board of directors since February 2021. He is the co-founder of Repare Therapeutics, where he served as President and Chief Executive Officer from its incorporation in 2016 through April 2025, and previously was a Managing Partner at Persistence Capital Partners and Entrepreneur-in-Residence at Versant Ventures. He received a BA in Politics from Brandeis University and an MBA from Harvard Business School.

Roles

Aktis Oncology, Inc.
Director · Current role
February 2021–present
Repare Therapeutics, Inc.
Co-Founder, President and Chief Executive Officer
2016 - April 2025
Persistence Capital Partners
Managing Partner
February 2010 - January 2016
Versant Ventures
Entrepreneur-in-Residence
June 2016 - March 2020

Also at Aktis Oncology, Inc.

Related

See how Top Bucket AI works for your firm

Request Demo
Top Bucket AI Research

Stay ahead of private markets

Research and market intelligence for private-markets professionals.

✓

You're subscribed.

Thanks for signing up.